NASDAQ:ADAP
Adaptimmune Therapeutics plc
- Stock
Last Close
0.05
27/10 22:32
Market Cap
293.91M
Beta: 2.24
Volume Today
564.86K
Avg: 683.17K
PE Ratio
−1.68
PFCF: −2.03
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 14.20M - | 37.83M 166.47% | 59.51M 57.28% | 1.12M 98.11% | 3.96M 252.76% | 6.15M 55.36% | 27.15M 341.50% | 60.51M 122.91% | 178.03M 194.20% | ||
cost of revenue | 9.86M - | 70K 99.29% | |||||||||
gross profit | 14.20M - | 37.83M 166.47% | 59.51M 57.28% | 1.12M 98.11% | 3.96M 252.76% | 6.15M 55.36% | 27.15M 341.50% | 50.66M 86.60% | 177.96M 251.30% | ||
selling and marketing expenses | -25.99M - | 506K 101.95% | |||||||||
general and administrative expenses | 23.21M - | 31.11M 34.03% | 43.60M 40.17% | 43.39M 0.48% | 45.80M 5.54% | 57.30M 25.13% | 63.39M 10.61% | 71.81M 13.29% | 80.81M 12.53% | ||
selling general and administrative expenses | 23.21M - | 31.11M 34.03% | 43.60M 40.17% | 43.39M 0.48% | 45.80M 5.54% | 57.30M 25.13% | 63.39M 10.61% | 45.82M 27.71% | 81.31M 77.45% | ||
research and development expenses | 63.79M - | 87.39M 37.00% | 98.27M 12.45% | 97.50M 0.78% | 91.57M 6.09% | 111.09M 21.32% | 127.73M 14.98% | 142.60M 11.65% | 149.06M 4.53% | ||
other expenses | -726.50K - | 1.00M 237.92% | 8.74M 772.65% | -15.50M 277.28% | 75K 100.48% | 1.16M 1,449.33% | 3.85M 231.50% | -536K 113.91% | -807K 50.56% | 16.35M 2,126.15% | |
cost and expenses | 87.00M - | 118.49M 36.20% | 141.87M 19.73% | 140.89M 0.69% | 137.36M 2.50% | 168.40M 22.59% | 191.11M 13.49% | 198.28M 3.75% | 246.79M 24.47% | ||
operating expenses | 33.79M - | 87.00M 157.46% | 118.49M 36.20% | 141.87M 19.73% | 140.89M 0.69% | 137.36M 2.50% | 168.40M 22.59% | 191.11M 13.49% | 188.42M 1.41% | 246.72M 30.94% | |
interest expense | -508.24K - | 2.23M - | 376K 83.14% | -1.01M - | 3.35M - | ||||||
ebitda | -69.51M - | -75.24M 8.24% | -74.56M 0.91% | -131.76M 76.73% | -125.81M 4.52% | -155.68M 23.74% | -157.89M 1.42% | -127.91M 18.99% | -52.66M 58.83% | ||
operating income | -72.80M - | -80.66M 10.80% | -82.36M 2.11% | -139.77M 69.70% | -133.41M 4.55% | -162.25M 21.62% | -163.97M 1.06% | -137.77M 15.98% | -68.76M 50.09% | ||
depreciation and amortization | 3.29M - | 5.42M 65.03% | 7.81M 44.02% | 8.01M 2.56% | 7.59M 5.19% | 6.57M 13.52% | 6.08M 7.49% | 9.86M 62.26% | 11.23M 13.93% | ||
total other income expenses net | 1.00M - | 8.74M 772.65% | -15.50M 277.28% | 2.85M 118.37% | 3.48M 22.06% | 4.95M 42.36% | 1.01M 79.66% | 9.19M 813.77% | 1.52M 83.44% | ||
income before tax | -70.69M - | -69.69M 1.41% | -95.02M 36.35% | -136.92M 44.10% | -129.93M 5.11% | -157.30M 21.06% | -162.96M 3.60% | -128.57M 21.10% | -67.24M 47.70% | ||
income tax expense | 892K - | 451K 49.44% | 497K 10.20% | 242K 51.31% | 162K 33.06% | 791K 388.27% | 2.50M 215.68% | -14.26M 671.13% | 3.58M 125.08% | ||
net income | -21.59M - | -71.58M 231.56% | -70.14M 2.01% | -95.51M 36.18% | -137.16M 43.61% | -130.09M 5.16% | -158.09M 21.52% | -165.46M 4.66% | -114.31M 30.91% | -70.81M 38.05% | |
weighted average shs out | 35.78M - | 70.79M 97.81% | 87.94M 24.23% | 97.39M 10.75% | 104.97M 7.78% | 142.46M 35.72% | 155.81M 9.36% | 161.21M 3.47% | 201.07M 24.73% | 252.30M 25.48% | |
weighted average shs out dil | 35.78M - | 70.79M 97.81% | 87.94M 24.23% | 97.39M 10.75% | 104.97M 7.78% | 142.46M 35.72% | 155.81M 9.36% | 161.21M 3.47% | 201.07M 24.73% | 252.30M 25.48% | |
eps | -0.60 - | -1.01 68.33% | -0.80 20.79% | -0.98 22.50% | -1.31 33.67% | -0.91 30.53% | -1.01 10.99% | -1.03 1.98% | -0.57 44.66% | -0.28 50.88% | |
epsdiluted | -0.60 - | -1.01 68.33% | -0.80 20.79% | -0.98 22.50% | -1.31 33.67% | -0.91 30.53% | -1.01 10.99% | -1.03 1.98% | -0.57 44.66% | -0.28 50.88% |
All numbers in USD (except ratios and percentages)